Company news

Wave Life Sciences Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Wave Life Sciences to Webcast Conference Call of First Quarter 2021 Financial Results on May 13, 2021

May 2, 2021

Wave Life Sciences Provides Update on Phase 1b/2a PRECISION-HD Trials

March 28, 2021

Wave Life Sciences to Present at the Third Annual Stifel CNS Day

March 18, 2021

Wave Life Sciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

March 3, 2021

Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2020 Financial Results on March 4, 2021

February 22, 2021

Wave Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference

February 15, 2021

Wave Life Sciences Highlights Pipeline Progress and Expansion Leveraging New PN Backbone Chemistry Modifications

January 10, 2021

Wave Life Sciences Announces Appointment of Jonathan Rosin as Chief Human Resources Officer

December 1, 2020

Wave Life Sciences to Present at the 29th Annual Credit Suisse Healthcare Conference

November 9, 2020

Wave Life Sciences Reports Third Quarter 2020 Financial Results and Provides Business Update

November 8, 2020

Wave Life Sciences to Webcast Conference Call of Third Quarter 2020 Financial Results on November 9, 2020

October 25, 2020

Wave Life Sciences to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference

September 27, 2020

Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares

September 21, 2020

Wave Life Sciences to Highlight Preclinical ADAR Editing Data and Neurology Programs at TIDES and OTS Annual Meetings

September 14, 2020

Wave Life Sciences to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

September 9, 2020

Wave Life Sciences Reports Second Quarter 2020 Financial Results and Provides Business Update

August 9, 2020

Wave Life Sciences to Highlight PRISM Platform Advancements and Preclinical Neurology Pipeline During Analyst and Investor Research Webcast

August 5, 2020

Wave Life Sciences to Webcast Conference Call of Second Quarter 2020 Financial Results on August 10, 2020

July 26, 2020

Wave Life Sciences Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update

March 1, 2020

Wave Life Sciences to Present at the Cowen and Company 40th Annual Healthcare Conference

February 18, 2020

Wave Life Sciences to Present Preclinical In Vivo and In Vitro Data for SNP3-Targeting Huntington’s Disease Program at CHDI Foundation’s 15th Annual HD Therapeutics Conference

February 17, 2020

Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2019 Financial Results on March 2, 2020

February 12, 2020

Wave Life Sciences Announces Topline Data and Addition of Higher Dose Cohort in Ongoing Phase 1b/2a PRECISION-HD2 Trial in Huntington’s Disease

December 29, 2019

Wave Life Sciences Announces Discontinuation of Suvodirsen Development for Duchenne Muscular Dystrophy

December 15, 2019

Wave Life Sciences Reports Third Quarter 2019 Financial Results and Provides Business Update

November 4, 2019

Wave Life Sciences Announces Fast Track Designation from U.S. FDA for Suvodirsen

September 15, 2019

← Newer news releases

Calls

The 5 newest of 25 calls. Every call is listed under its year.

Decks

The 5 newest of 97 decks. Every deck is listed under its year.